skip to main content columnskip to left navigationskip to horizontal navigation

College of Public Health

Dr. Kesheng Wang Part of Inter-Professional Team to Study HIV Treatment

Dr. Kesheng Wang, Associate Professor in the Department of Biostatistics and Epidemiology, is a Co-Investigator on an interdisciplinary project led by Dr. Sam Harirforoosh of the Department of Pharmaceutical Sciences in the Bill Gatton College of Pharmacy.  Their project will be a collaboration between scientists from the Colleges of Medicine, Public Health and Pharmacy.  The medication STRIBILD® is indicated as a complete regimen for the treatment of HIV-1 infection in adult patients who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically-suppressed.  The proposal tests the hypothesis that the genetic makeup of an individual influences STRIBILD® pharmacokinetics and subsequent pharmacodynamics and attempts to characterize patient response as an expression of that genetic makeup. 

The study will consist of 120 HIV-infected adults on the STRIBILD® regimen.  A blood sample will be collected for genotyping and drug trough concentration evaluation.  The researchers state a selective understanding of gene interactions could help to personalize STRIBILD usage in managing HIV.  A reviewer of the funding proposal states, “Dr. Harirforoosh has put together a(n) interdisciplinary team of scientists…where each of the contributors bring a unique role critical to the mission…This research is utilizing the skill sets residing in the Academic Health Science Center and leveraging them to create synergy to optimize ETSU's experts.”

icon for left menu icon for right menu